Menu

rss
Br J Ophthalmol 89:1646-1654 doi:10.1136/bjo.2005.072546
  • Perspective

Hypertensive retinopathy revisited: some answers, more questions

  1. A Grosso1,
  2. F Veglio2,
  3. M Porta3,
  4. F M Grignolo1,
  5. T Y Wong4
  1. 1Department of Clinical Physiopathology, Ophthalmology Section Turin University, Italy
  2. 2Department of Medicine and Experimental Oncology, Turin University, Italy
  3. 3Department of Internal Medicine, Turin University, Italy
  4. 4Centre for Eye Research Australia, University of Melbourne, Australia, and Singapore Eye Research Institute, National University of Singapore, Singapore
  1. Correspondence to: Andrea Grosso MD, Department of Clinical Physiopathology, Ophthalmology Section, Turin University, Via Juvarra, 19, 10122 Turin, Italy; 78andrea1tin.it
  • Accepted 1 July 2005

Abstract

Hypertension is associated with cardiovascular risk and systemic target organ damage. Retinopathy is considered one of the indicators of target organ damage. This review focuses on recent studies on hypertensive retinopathy and their implications for clinical care. Early recognition of hypertensive retinopathy signs remains an important step in the risk stratification of hypertensive patients.

Footnotes